IBS C News and Research

RSS

Gastrointestinal symptoms in children could be a red flag for future mental health problems

A Columbia University study has found that adversity early in life is associated with increased gastrointestinal symptoms in children that may have an impact on the brain and behavior as they grow to maturity.

29 Mar 2019

Most pills contain common allergens, warn experts

Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.

20 Mar 2019

Gluten, lactose, food dyes in pills could be causing side effects finds study

Pills or oral medications contain inactive ingredients. Some of these may be responsible for the side effects says a new study. The study results appeared in an article published in the latest issue of the journal Science Translational Medicine.

18 Mar 2019

Fecal transplantation improves the gut of IBS patients

Transplantation of feces from a healthy person to a patient suffering of irritable bowel syndrome improved both symptoms of IBS and the gut's bacteria profile.

7 Mar 2019

Stressed IBS sufferers exhibit a distinctive microbial signature in the gut

People who suffer from stress-related Irritable Bowel Syndrome have a distinctive microbial signature in their gut.

5 Mar 2019

Low FODMAP diet reduces stomach issues caused by exercise

Research indicates that cutting out specific foods can alleviate the gastrointestinal issues some people experience when they exercise, with over two-thirds of people involved in a new study reporting an improvement.

14 Feb 2019

Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board

Bedfont announces today that Dr Jafar Jafari will be the first appointment to its Gastrolyzer Medical Advisory Board.

From Bedfont® Scientific Ltd 18 Jan 2019

Online CBT can help treat gastrointestinal disorders in children

Cognitive behavioral therapy online can be useful in treating gastrointestinal disorders in children when no physical cause can be found. This is the viewpoint of researchers at Karolinska Institutet in Sweden that is described in a new study published in the journal Clinical Gastroenterology and Hepatology.

7 Dec 2018

Gut-directed hypnotherapy may offer new treatment option for IBS patients

Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care.

23 Nov 2018

Increased physical activity associated with improvement in IBS symptoms

Increased physical activity is now being emphasized as a treatment option for the gastric intestinal disease known as IBS. Research at Sahlgrenska Academy, Sweden, indicates improvements in both intestinal function and self-esteem of patients who exercise more.

25 Sep 2018

Understanding How Antibodies Shape the Gut Microbiome

Dr. Keiichiro Suzuki discusses the importance of IgA in the human body, and his recent research study, which showed that IgA interacts with the gut microbiome and promotes the growth of healthy bacteria.

20 Aug 2018

Study: 11% of IBS-D patients suffer from suicidal thinking when their condition is bad

Eleven percent of irritable bowel syndrome with diarrhoea (IBS-D) patients reveal that they suffer from suicidal thinking when their condition is bad, a new study has found.

10 Aug 2018

Study identifies constellation of metabolites linked to ME/CFS

A study led by researchers at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health has identified a constellation of metabolites related to myalgic encephalomyelitis/chronic fatigue syndrome.

10 Jul 2018

American College of Gastroenterology releases monograph on IBS management

The American College of Gastroenterology is pleased to announce that its Monograph on Management of Irritable Bowel Syndrome was published this week in The American Journal of Gastroenterology, the College's flagship journal.

30 Jun 2018

Cedars-Sinai study identifies gut gas associated with diarrhea

Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses-;small intestine bacterial overgrowth and irritable bowel syndrome.

6 Jun 2018

Acoustic technology could offer new way to diagnose IBS

Utilizing newly adapted artificial intelligence, researchers have developed an acoustic belt that offers a new way to diagnose irritable bowel syndrome by listening to the noises in a patient's gut, according to research presented at Digestive Disease Week 2018.

5 Jun 2018

Home-based treatment program offers robust and sustained relief for IBS patients

In the largest federally funded non-drug clinical trial for irritable bowel syndrome, patients with the most severe and persistent symptoms achieved robust and sustained relief by learning to control symptoms with minimal clinician contact. Led by University at Buffalo researchers in collaboration with colleagues at New York University and Northwestern University, the study was published online before print in Gastroenterology.

23 Apr 2018

Research links DNA variants to increased risk of IBS in women

New research coordinated by Karolinska Institutet in Sweden links certain DNA variants to increased risk of irritable bowel syndrome in women. The findings, published in the scientific journal Gastroenterology, might help explain why IBS is more common in women than in men.

5 Apr 2018

New review explores potentially safer therapies for treating chronic abdominal pain

An estimated 2 million people in the U.S. are addicted to prescription opioids- powerful doctor-prescribed medications for chronic or severe pain. The drugs are commonly prescribed to treat gastrointestinal pain caused by conditions such as Crohn's disease and irritable bowel syndrome (IBS), raising the risk of addiction among this population.

29 Mar 2018

IQuity launches pioneering RNA-based blood test to diagnose fibromyalgia

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia™, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly detect fibromyalgia syndrome.

5 Mar 2018